Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-19

FDA Approved: MONO-LINYAH — Supplemental Application (Northstar Rx LLC)

View source ↗

Summary

FDA approved the supplemental application for MONO-LINYAH (norgestimate and ethinyl estradiol) by Northstar Rx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MONO-LINYAH (NORGESTIMATE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for MONO-LINYAH (NORGESTIMATE AND ETHINYL ESTRADIOL)